Human Longevity Investor

Human Longevity, Inc. (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. HLI’s business areas include the HLI Health Nucleus, a genomic powered clinical research center which uses whole genome sequence analysis, advanced clinical imaging and innovative machine learning, along with curated personal health information, to deliver the most complete picture of individual health; HLIQ™ Whole Genome and HLIQ Oncology.

Invests into
Industry: Regenerative Medicine
Headquarters: San Diego, California, United States
Founded Date: 2013
Employees Number: 501-1000
Funding Status: Early Stage Venture
Investor Type: N/A
Investment Stage: N/A
Number Of Exits: N/A

Visit Website
clientservices@humanlongevity.com
@humanlongevity
Register and Claim Ownership